• Regorafenib (BAY 73-4506): Unlocking Translational Oncology

  2026-07-01

  This article bridges mechanistic insight and translational strategy, highlighting how Regorafenib (BAY 73-4506) redefines preclinical oncology workflows by targeting angiogenesis and RRM2-driven pathways. Drawing from recent mechanistic advances in melanoma and integrating practical guidance, it positions APExBIO's Regorafenib as an essential tool for translational researchers seeking robust, reproducible outcomes.

• Nicotine Signaling Drives CKD Progression: Mechanistic Insig

  2026-06-30

  This review by Jain and Jaimes dissects the mechanistic role of nicotine in accelerating chronic kidney disease (CKD) progression among smokers. Integrating clinical and experimental evidence, the paper highlights nicotine’s effects on non-neuronal nAChRs, oxidative stress, and pro-fibrotic pathways, offering a focused perspective on potential research targets for CKD intervention.

• Fluorescein TSA Fluorescence System Kit: Precision Signal Am

  2026-06-30

  The Fluorescein TSA Fluorescence System Kit empowers researchers to push fluorescence detection to its sensitivity limits, making it possible to visualize and quantify low-abundance biomolecules in fixed tissues and cells. By integrating robust tyramide signal amplification with standardized workflows, this kit transforms routine immunohistochemistry, immunocytochemistry, and in situ hybridization into high-resolution, reproducible assays.

• PRMT5-Driven Spliceosomal Vulnerability in MYCN-Amplified Ne

  2026-06-29

  This study uncovers how PRMT5 regulates both epitranscriptomic and metabolic pathways, creating a spliceosomal vulnerability in MYCN-amplified neuroblastoma. The findings highlight the central role of glutamine metabolism and splicing regulation, offering new angles for targeting cancer metabolism in high-risk pediatric neuroblastoma.

• D-Luciferin (potassium salt): Reliable Bioluminescence for C

  2026-06-29

  This article examines common laboratory challenges in cell viability and imaging assays, offering evidence-based solutions centered on D-Luciferin (potassium salt) (SKU C3654). Leveraging real-world scenarios, it highlights how this substrate from APExBIO ensures experimental reproducibility, sensitivity, and workflow efficiency in both in vivo and in vitro applications.

• AMG 487 and the CXCL10-CXCR3 Axis: Redefining Macrophage Pol

  2026-06-28

  Explore how AMG 487, a potent CXCR3 antagonist, uniquely disrupts the CXCL10-CXCR3 axis to modulate macrophage polarization in inflammation and lung injury. This article delivers new scientific depth and practical assay insights beyond prior reviews.

• Reserpine (N1867): Technical Guidance for Lab Research Workf

  2026-06-27

  Reserpine is a high-purity, bioactive natural product used primarily in neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology. It is not suitable for diagnostic, clinical, or veterinary applications, and must be handled with strict protocol adherence to maintain reproducibility and compound integrity.

• Amikacin Disulfate: Applied Workflows in Antibiotic Mechanis

  2026-06-26

  Amikacin disulfate stands out as a semisynthetic aminoglycoside antibiotic enabling precise studies of bacterial protein synthesis suppression and ribosomal interactions. This article details optimized experimental workflows, troubleshooting advice, and practical insights based on the latest research, empowering scientists to dissect antibiotic mechanisms and resistance with greater accuracy.

• Gli1+ Progenitors Drive Glucocorticoid-Induced Osteoporosis

  2026-06-26

  This study establishes Gli1+ metaphyseal mesenchymal progenitors (MMPs) as critical mediators of glucocorticoid-induced osteoporosis. Through lineage tracing and single-cell transcriptomics, the research reveals that glucocorticoids impair bone formation by targeting the proliferation and differentiation of Gli1+ MMPs, offering new mechanistic insight with practical implications for osteoporosis intervention.

• Triamcinolone Protocols: Technical Guidance for Research Use

  2026-06-25

  Triamcinolone is a synthetic glucocorticoid agonist optimized for in vitro research on glucocorticoid signaling, inflammation, and immunosuppression. It is not suitable for diagnostic or clinical applications, and reproducibility depends on careful attention to solubility and storage requirements.

• Practical Guide to Angiotensin I/II (1-5) in RAS Research

  2026-06-25

  Angiotensin I/II (1-5) is a defined Asp-Arg-Val-Tyr-Ile peptide fragment used to model the renin-angiotensin system in hypertension and renal signaling workflows. It is not suitable for applications outside cardiovascular or renal function research due to its specific mechanistic and solubility properties. Researchers should use it only in validated blood pressure and aldosterone pathway assays.

• Ceftazidime in the Era of Plasmid-Mediated Resistance: Resea

  2026-06-24

  Explore the pivotal role of Ceftazidime, a third-generation cephalosporin, in contemporary bacterial resistance research. This article uniquely dissects plasmid-borne resistance mechanisms and their implications for infection models and assay design.

• Cytochalasin D (SKU B6645): Reliable Actin Polymerization In

  2026-06-23

  This article provides practical, scenario-driven guidance for using Cytochalasin D (SKU B6645) as a reproducible actin polymerization inhibitor in cell-based assays. We address common lab challenges, protocol optimization, and the comparative reliability of APExBIO’s reagent, supporting each recommendation with data and literature links.

• Angiotensin II in Vascular Pathology: Cellular Plasticity an

  2026-06-23

  Discover how Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) shapes vascular disease by driving smooth muscle cell phenotypic transitions and inflammation. This article uniquely bridges peptide signaling, experimental protocol precision, and the latest insights from vascular remodeling research.

• Sulfo-Cy5 Carboxylic Acid: Fluorescent Dye for Life Sciences

  2026-06-22

  Sulfo-Cy5 carboxylic acid enables high-sensitivity, water-based fluorescence imaging with reduced quenching—ideal for protein and peptide labeling. Its hydrophilic, sulfonated structure streamlines advanced immunological and neuroscience assays where reproducibility and signal clarity are paramount.

453 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page